Misspellings or "miscellings"-Non-verifiable and unknown cell lines in cancer research publications

被引:7
|
作者
Oste, Danielle J. [1 ,2 ]
Pathmendra, Pranujan [1 ]
Richardson, Reese A. K. [3 ]
Johnson, Gracen [1 ]
Ao, Yida [1 ]
Arya, Maya D. [1 ]
Enochs, Naomi R. [1 ]
Hussein, Muhammed [1 ]
Kang, Jinghan [1 ]
Lee, Aaron [1 ]
Danon, Jonathan J. [4 ]
Cabanac, Guillaume [5 ,6 ]
Labbe, Cyril [7 ]
Davis, Amanda Capes [8 ]
Stoeger, Thomas [9 ,10 ,11 ]
Byrne, Jennifer A. [1 ,12 ,13 ,14 ]
机构
[1] Univ Sydney, Fac Med & Hlth, Sch Med Sci, Sydney, NSW, Australia
[2] Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Sydney, NSW, Australia
[3] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA
[4] Univ Sydney, Fac Sci, Sch Chem, Sydney, NSW, Australia
[5] Univ Toulouse, IRIT UMR CNRS 5505, Toulouse, France
[6] Inst Univ France IUF, Paris, France
[7] Univ Grenoble Alpes, CNRS, Grenoble INP, Lab Informat Grenoble, Grenoble, France
[8] Univ Sydney, Childrens Med Res Inst, CellBank Australia, Sydney, NSW, Australia
[9] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL USA
[10] Northwestern Univ, Potocsnak Longev Inst, Chicago, IL USA
[11] Simpson Querrey Lung Inst Translat Sci, Chicago, IL USA
[12] NSW Hlth Pathol, NSW Hlth Statewide Biobank, Sydney, NSW, Australia
[13] NSW Hlth Pathol, Sydney, NSW, Australia
[14] Univ Sydney, Sydney, NSW, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
cancer; cell lines; non-verifiable; reagents; wrongly identified; BIOMARKER DISCOVERY; REPRODUCIBILITY; MIR-143/145; SEQUENCES; PRIMER; NEED;
D O I
10.1002/ijc.34995
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Reproducible laboratory research relies on correctly identified reagents. We have previously described gene research papers with wrongly identified nucleotide sequence(s), including papers studying miR-145. Manually verifying reagent identities in 36 recent miR-145 papers found that 56% and 17% of papers described misidentified nucleotide sequences and cell lines, respectively. We also found 5 cell line identifiers in miR-145 papers with misidentified nucleotide sequences and cell lines, and 18 cell line identifiers published elsewhere, that did not represent indexed human cell lines. These 23 identifiers were described as non-verifiable (NV), as their identities were unclear. Studying 420 papers that mentioned 8 NV identifier(s) found 235 papers (56%) that referred to 7 identifiers (BGC-803, BSG-803, BSG-823, GSE-1, HGC-7901, HGC-803, and MGC-823) as independent cell lines. We could not find any publications describing how these cell lines were established. Six cell lines were sourced from cell line repositories with externally accessible online catalogs, but these cell lines were not indexed as claimed. Some papers also stated that short tandem repeat (STR) profiles had been generated for three cell lines, yet no STR profiles could be identified. In summary, as NV cell lines represent new challenges to research integrity and reproducibility, further investigations are required to clarify their status and identities. Reproducible laboratory research relies on correctly identified reagents. Here, the authors flagged 23 non-verifiable (NV) human cell line identifiers in recent papers. Although some NV identifiers are likely mere misspellings of known cell lines, the results indicate that some misspelled cell lines can gain new identities as independent cell lines, a process the authors describe as "miscelling." Of the eight identifiers studied in detail, seven NV identifiers were unexpectedly referred to as independent cell lines across 235 publications, lacking a description of how they were established, not appearing in the claimed external repositories, and having no short tandem repeat profile. image
引用
收藏
页码:1278 / 1289
页数:12
相关论文
共 50 条
  • [31] Functional characterization of gefitinib uptake in non-small cell lung cancer cell lines
    Galetti, Maricla
    Alfieri, Roberta R.
    Cavazzoni, Andrea
    La Monica, Silvia
    Bonelli, Mara
    Fumarola, Claudia
    Mozzoni, Paola
    De Palma, Giuseppe
    Andreoli, Roberta
    Mutti, Antonio
    Mor, Marco
    Tiseo, Marcello
    Ardizzoni, Andrea
    Petronini, Pier Giorgio
    BIOCHEMICAL PHARMACOLOGY, 2010, 80 (02) : 179 - 187
  • [32] Establishment of pemetrexed-resistant non-small cell lung cancer cell lines
    Zhang, Dan
    Ochi, Nobuaki
    Takigawa, Nagio
    Tanimoto, Yasushi
    Chen, Yanyan
    Ichihara, Eiki
    Hotta, Katsuyuki
    Tabata, Masahiro
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    CANCER LETTERS, 2011, 309 (02) : 228 - 235
  • [33] Comparative proteome analysis across non-small cell lung cancer cell lines
    Grundner-Culemann, Kathrin
    Dybowski, J. Nikolaj
    Klammer, Martin
    Tebbe, Andreas
    Schaab, Christoph
    Daub, Henrik
    JOURNAL OF PROTEOMICS, 2016, 130 : 1 - 10
  • [34] Paclitaxel administration and its effects on clinically relevant human cancer and non cancer cell lines
    McAuliffe, G
    Roberts, L
    Roberts, S
    BIOTECHNOLOGY LETTERS, 2002, 24 (12) : 959 - 964
  • [35] Toxicity assessment of magnesium oxide nano and microparticles on cancer and non-cancer cell lines
    Mangalampalli, Bhanuramya
    Dumala, Naresh
    Grover, Paramjit
    NUCLEUS-INDIA, 2019, 62 (03): : 227 - 241
  • [36] Mechanisms of growth stimulation by suramin in non-small-cell lung cancer cell lines
    Lokshin, A
    Peng, XJ
    Campbell, PG
    Barsouk, A
    Levitt, ML
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (04) : 341 - 347
  • [37] Comparative cytotoxicity of oxaliplatin and cisplatin in non-seminomatous germ cell cancer cell lines
    T.A. Dunn
    H.J. Schmoll
    V. Grünwald
    V. Bokemeyer
    J. Casper
    Investigational New Drugs, 1997, 15 : 109 - 114
  • [38] The influence of erythropoietin on growth and survival in non-small cell lung cancer cell lines
    Frille, Armin
    Leithner, Katharina
    Hrzenjak, Andelko
    Olschewski, Andrea
    Olschewski, Horst
    Wohlkoenig, Christoph
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [39] Amphiregulin induces resistance to gefitinib in non-small cell lung cancer cell lines
    Busser, Benoit
    Lucie, Sancey
    Marie, Favrot
    Luc, Coll Jean
    Amandine, Hurbin
    BULLETIN DU CANCER, 2009, 96 : S55 - S55
  • [40] The study of cytotoxic activity of new berberine derivatives on cancer and non-cancer cell lines
    Svedova, Alexandra
    Milata, Viktor
    Jantova, Sona
    TOXICOLOGY LETTERS, 2017, 280 : S227 - S227